Phase 3
Completed N=26
Emergency Treatment of Coral Snake Envenomation With Antivenom
Coral Snake Bite · Toxic Effect of Coral Snake Venom
Source: ClinicalTrials.gov NCT01337245 ↗
Enrolled (actual)
26
Serious AEs
11.5%
Results posted
Apr 2023
Primary outcomePrimary: Number of Participants Who Survived — 25 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake.
Funding Source - FDA OOPD.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Survived |
25 | — |
| SECONDARY Change in Mean Venom Level From Baseline to 24 Hours |
-34.5 | — |
| SECONDARY Change in Mean Antivenom Level From Baseline to 24 Hours |
112.4 | — |
Eligibility Criteria
Inclusion Criteria
- Male or female of any age. Presenting for emergency treatment of coral snake bite.
Exclusion Criteria
- Prior use of coral snake antivenom for this envenomation. Allergy to horse serum.
Data sourced from ClinicalTrials.gov (NCT01337245). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.